相似文献
1
[Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
Nihon Gan Chiryo Gakkai Shi. 1984 Aug 20;19(7):1496-504.
2
[Tissue polypeptide antigen in gynecological cancer].
Gan No Rinsho. 1985 Jan;31(1):65-72.
3
[Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Dec;37(12):2872-5.
4
[Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Sep;37(9):1883-92.
5
[Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Nov;37(11):2361-8.
6
Clinical significance of statistical discrimination employing serum TA-4, TPA, and CEA levels in uterine cervical cancer.
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Oct;38(10):1770-6.
7
[A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Oct;36(10):1877-83.
8
Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Feb;41(2):217-24.
9
Clinical significance of different serum tumor markers in gynecological malignancies.
Cancer Detect Prev. 1985;8(1-2):115-20.
10
[The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Gan No Rinsho. 1985 May;31(5):544-8.
Zotero 插件